Related Experiment Video
Updated: Mar 23, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
14.0K
[Thalidomide induced peripheral neuropathy in multiple myeloma patients]
Przeglad Lekarski
|March 26, 2016
Summary
Over 60% of multiple myeloma patients treated with thalidomide develop peripheral neuropathy. Early electrophysiological studies are recommended to detect nerve damage and allow for dose adjustments or alternative treatments.
Area of Science:
- Neuroscience
- Oncology
- Pharmacology
Context:
- Thalidomide is an effective multiple myeloma treatment.
- Thalidomide causes peripheral neuropathy as a significant side effect.
- Peripheral neuropathy impacts patient quality of life and treatment adherence.
Purpose:
- To assess the prevalence of peripheral neuropathy in multiple myeloma patients treated with thalidomide.
- To clinically and electrophysiologically evaluate thalidomide-induced neuropathy.
- To establish the incidence of specific nerve entrapment syndromes alongside polyneuropathy.
Summary:
- A study of 43 multiple myeloma patients treated with thalidomide revealed peripheral neuropathy in over 60%.
- Electrophysiological assessments identified polyneuropathy in 27 patients, with coexisting carpal tunnel syndrome in 6.
- 10 patients had normal electrophysiological results, while others showed specific nerve damage.
Impact:
- Highlights the high risk of peripheral neuropathy with thalidomide therapy.
- Recommends routine electrophysiological screening for early neuropathy detection in multiple myeloma patients.
- Suggests dose modification or alternative drugs to mitigate neurotoxicity while maintaining cancer treatment efficacy.
More Related Videos
Related Concept Videos
01:16Drug toxicity: Idiosyncratic Reactions
162
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
162
01:29Therapeutic Drug Monitoring: Affecting Factors
323
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
323
01:24Drug Toxicity: Dose-Dependent Reactions
145
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
145
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.0K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.0K
01:28Diphtheria
37
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
37
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
786
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
786